OPT used in research to measure changes in tumour volume
3 April 2012
Researchers at the Breakthrough Breast Cancer Research Unit have used OPT imaging to measure changes in tumour volume in ER+ breast tumours. They have published a paper entitled "Determining tamoxifen sensitivity using primary breast cancer tissue in collagen-based three-dimensional culture" in Biomaterials journal.
OPT (optical projection tomography) is a 3d imaging technique invented by Dr James Sharpe at the MRC Human Genetics Unit, and has been further developed by MRC Technology's Centre for Lifescience Technologies.
For more information about OPT, please visit Bioptonics.